Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)

BACKGROUND: It has been suggested to replace the diagnosis-specific graded prognostic assessment (DS-GPA, based on performance status and number of brain metastases) for patients with primary malignant melanoma with the new Melanoma-molGPA. The latter is a more complex assessment, which also include...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Hintz, Mandy, Bilger, Angelika, Oehlke, Oliver, Grosu, Anca-Ligia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798262/
https://www.ncbi.nlm.nih.gov/pubmed/29416574
http://dx.doi.org/10.14740/jocmr3248w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798262/
https://www.ncbi.nlm.nih.gov/pubmed/29416574
http://dx.doi.org/10.14740/jocmr3248w

Ejemplares similares